SCLX — Scilex Holding Co

—
Nasdaq · Health Care · Biotechnology · CIK 1820190 ·
Last close
$4.49
Market Cap
$31.59M
52W High
$18.58
52W Low
$2.62
ADV30
38,920
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 7,642,000 3,965,000 -29,423,000 -113,500,000 253,562,000 566,000 564,050,000
Mar 2026 8,613,000 4,166,000 -32,169,000 -43,270,000 293,635,000 3,351,000 547,705,000
Dec 2025 4,793,000 2,179,000 -37,482,000 -33,112,000 364,981,000 4,955,000 576,734,000
Sep 2025 10,560,000 7,231,000 -186,512,000 -257,234,000 275,879,000 878,000 455,598,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-13,805,000
Investing CF
$-4,681,000
Financing CF
$6,767,000
CapEx
$-3,633,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-38.13
As of
2026-08-16

Balance + Analyst (yfinance extras)

Retained Earnings
$-965,056,000
Inventory
$4,532,000
Receivables
$29,847,000
ST Investments
$10,000
EBIT TTM
$-371,138,000
Pretax Income TTM
$-393,597,000
Interest Exp TTM
$11,459,000
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$31,608,000
EBITDA
$-277,268,000
Free Cash Flow
$-8,842,550
Enterprise Value
$138,482,032
Total Cash
$581,000
Total Debt
$105,985,000
Shares Out
7,034,737
Trailing EPS
$-49.73
Book Value
$-43.83
ROE
—
ROA
-105.8%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 30,253,000 -272,304,000 -358,734,000 364,981,000 576,734,000 -207,782,000 3,816,000
Dec 2024 56,590,000 -92,787,000 -72,807,000 92,953,000 285,596,000 -192,643,000 19,349,000
Dec 2023 46,743,000 -105,431,000 -114,331,000 101,309,000 274,247,000 -172,938,000 -20,707,000
Dec 2022 38,034,000 -50,634,000 -23,364,000 86,527,000 50,288,000 36,239,000 -21,258,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.73

Peers — same industry

TickerNameMarket CapLastDaily %
ALGS Aligos Therapeutics, Inc. $30.16M $5.54 —
GNTA Genenta Science S.p.A. $33.28M $0.69 —
CVM CEL SCI CORP $29.90M $1.70 —
QNCX Quince Therapeutics, Inc. $29.49M $29.00 —
EVAX Evaxion A/S $29.23M $3.24 —

News headlines (Yahoo Finance, 1h cache)

Federal Court Grants Motion to Stay Proceedings in Scilex v. Wade et al.
2026-08-20 20:12 · Yahoo
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Inv
2026-07-07 10:00 · Yahoo
Scilex, Vera Therapeutics rise premarket; Strategy gains
2026-07-06 12:19 · Yahoo
Scilex Shares Jump After Securing $100 Million Strategic Investment Proposal (SCLX)
2026-07-06 11:33 · Yahoo
Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP
2026-07-06 10:00 · Yahoo
Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and ot
2026-06-12 11:45 · Yahoo
Scilex Holding Company (“Scilex”) Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and oth
2026-06-04 13:00 · Yahoo
Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securiti
2026-05-22 17:15 · Yahoo
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
2026-05-05 17:00 · Yahoo
Wade Defendants Dispute Complaint and Statement by Scilex Holding Company
2026-05-05 12:31 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.